Evidence map›Paper›PMID 33280522›Full record

ArticleTechnology in cancer research & treatment

Clinical Research on Systemic Chemotherapy Combined With Bronchoscopic Seed Implantation in the Treatment of Advanced Lung Cancer.

Feng Xu, Jian Yang, Beizheng Xu, Zhenzhen Li, Xuanmei Li, Xiaotang Wu, Haiyan Liu

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Feng XuDepartment of Pulmonary and Critical Care Medicine, Cangzhou People's Hospital, Cangzhou, China.
Jian YangDepartment of Radiation Oncology, Cangzhou People's Hospital, Cangzhou, China.
Beizheng XuTianjin Medical University, Tianjin, China.
Zhenzhen LiDepartment of Pulmonary and Critical Care Medicine, Cangzhou People's Hospital, Cangzhou, China.
Xuanmei LiDepartment of Pulmonary and Critical Care Medicine, Cangzhou People's Hospital, Cangzhou, China.
Xiaotang WuShanghai Engineering Research Center of Pharmaceutical Translation, Shanghai, China.
Haiyan LiuDepartment of Pulmonary and Critical Care Medicine, Cangzhou People's Hospital, Cangzhou, China.ORCID 0000-0002-0575-5416
People's Hospital of Cangzhou · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aims to explore the clinical value of systemic chemotherapy combined with bronchoscopic seed implantation in advanced lung cancer treatment.

methodsThe study enrolled 253 patients with advanced lung cancer in Cangzhou People's Hospital from March 2018 to March 2020, and they were divided into test group and control group. Test group was given systemic chemotherapy combined with bronchoscopic seed implantation, while control group was given systemic chemotherapy. The objective response rate of tumor (ORR), disease control rate (DCR), serum tumor marker level, survival time and adverse reactions of 2 groups were compared.

resultsAfter treatment, the levels of serum tumor markers including carcino-embryonic antigen, neuro-specific enolase, cytokeratin-19 and pro-gastrin-releasing peptide were markedly decreased in test group compared with those in control group (

conclusionThe efficacy of systemic chemotherapy combined with bronchoscopic seed implantation was superior to that of systemic chemotherapy, which is worthy of promoting in clinical practice.

Indexed as

BronchoscopyAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorDisease ManagementFemaleHumansIodine RadioisotopesLung NeoplasmsMaleMiddle AgedNeoplasm MetastasisNeoplasm StagingTomography, X-Ray ComputedBiomarkers, TumorIodine Radioisotopesbronchoscopelung cancerseed implantationsystemic chemotherapy

Identifiers

PMID33280522
PMCPMC7724264
OpenAlexW3113132713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.